Patents by Inventor David Vodak

David Vodak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240277619
    Abstract: The invention discloses a method for preparation of spray dried solid dispersions (SDD) comprising an active pharmaceutical ingredient (API) and a dispersion polymer (DISPPOL), wherein the spray drying is done with a supersaturated solution of API in a solvent mixture comprising two solvents, this supersaturated solution further comprising DISPPOL.
    Type: Application
    Filed: June 9, 2022
    Publication date: August 22, 2024
    Applicant: Lonza Bend Inc.
    Inventors: Michael Morgen, Molly Adam, John Baumann, Nathan Bennette, Michael Grass, Warren Miller, Amanda Pluntze, Daniel Regan, David Vodak
  • Publication number: 20240261225
    Abstract: The invention discloses a method for preparation of spray dried solid dispersions, SDD, comprising an active agent, AA, such as an active pharmaceutical ingredient, API, and a dispersion polymer, DISPPOL, wherein the spray drying is done with a solution of AA and of DISPPOL in a solvent comprising C1-3 alkanol and formic acid, and optionally water.
    Type: Application
    Filed: June 3, 2022
    Publication date: August 8, 2024
    Applicant: Lonza Bend Inc.
    Inventors: Michael Morgen, Warren Miller, David Vodak, Jonathan Cape, Molly Adam, Michael Grass
  • Publication number: 20240197628
    Abstract: The present disclosure relates to inhalable dry powder formulations comprising one or more antibodies or one or more angiogenesis inhibiting active pharmaceutical ingredients, methods of manufacture of such compositions, e.g., via spray drying, as well as their local administration to the lung for use in the treatment, prevention and/or delay of progression of asthma, COPD, lung infections, cystic fibrosis, or lung cancer.
    Type: Application
    Filed: February 28, 2024
    Publication date: June 20, 2024
    Applicant: Lonza Bend Inc.
    Inventors: Kimberly Shepard, Michael Banks, David Vodak
  • Publication number: 20240000707
    Abstract: The present invention relates to inhalable dry powder formulations comprising one or more antibodies or one or more angiogenesis inhibiting active pharmaceutical ingredients, methods of manufacture of such compositions, e.g. via spray drying, as well as their local administration to the lung for use in the treatment, prevention and/or delay of progression of asthma, COPD, lung infections, cystic fibrosis, or lung cancer.
    Type: Application
    Filed: November 17, 2021
    Publication date: January 4, 2024
    Applicant: Lonza Bend Inc.
    Inventors: Kimberly Shepard, Michael Banks, David Vodak
  • Publication number: 20230414515
    Abstract: The invention discloses a method for preparation of spray dried solid dispersions, SDD, comprising an active agent, AA, such as an active pharmaceutical ingredient, API, and a dispersion polymer, DISPPOL, wherein the spray drying is done with a solution of AA and of DISPPOL in a solvent comprising C1-3 alkanol and acetic acid, and optionally water.
    Type: Application
    Filed: September 30, 2021
    Publication date: December 28, 2023
    Applicant: Lonza Bend Inc.
    Inventors: Michael Morgen, Warren Miller, David Vodak, Jonathan Cape, Molly Adam
  • Publication number: 20230293439
    Abstract: The invention discloses a method for preparation of spray dried solid dispersions (SDD) comprising an active pharmaceutical ingredient (API) and a dispersion polymer (DISPPOL), wherein the spray drying is done with a supersaturated solution of API in a solvent mixture comprising two solvents, one is acetic acid, this supersaturated solution further comprising DISPPOL.
    Type: Application
    Filed: July 22, 2021
    Publication date: September 21, 2023
    Applicant: Lonza Bend Inc.
    Inventors: Molly Adam, John Baumann, Nathan Bennette, Warren Miller, Michael Morgen, Amanda Pluntze, Daniel Regan, David Vodak
  • Publication number: 20220361552
    Abstract: A composition containing a plurality of particles containing a core having a lipid matrix including an active ingredient dispersed therein is disclosed. The active ingredient can include a fat-soluble active ingredient. The particles can be contained in a capsule. Also provided are methods for producing a pharmaceutical composition containing a plurality of particles containing a core having a lipid matrix including an active ingredient dispersed therein.
    Type: Application
    Filed: December 10, 2020
    Publication date: November 17, 2022
    Inventors: Tyler White, Christopher Craig, David Vodak, Shane Durkee
  • Publication number: 20220151920
    Abstract: The present disclosure relates to inhalable dry powder formulations comprising one or more antibodies or one or more angiogenesis inhibiting active pharmaceutical ingredients, methods of manufacture of such compositions, e.g., via spray drying, as well as their local administration to the lung for use in the treatment, prevention and/or delay of progression of asthma, COPD, lung infections, cystic fibrosis, or lung cancer.
    Type: Application
    Filed: November 17, 2021
    Publication date: May 19, 2022
    Applicant: Bend Research, Inc.
    Inventors: Kimberly Shepard, Michael Banks, David Vodak